www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

C3b/iC3b/C3d, Human, mAb 1H8

Catalogue number:
HM2287-100UG
Supplier:
Size:
100 µg _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£410.00 Shipping is calculated in checkout
Applications:

Flow cytometry, Immuno precipitation, Western blot

Product Description:

The monoclonal antibody 1H8 recognizes Complement Factor C3b/iC3b/C3d, it specifically binds human C3 as well as the breakdown products C3b, iC3b and C3dg. C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. People with C3 deficiency are susceptible to bacterial infection.One form of C3-convertase, also known as C4b2a, is formed by a heterodimer of activated forms of C4 and C2. It catalyzes the proteolytic cleavage of C3 into C3a and C3b, generated during activation through the classical pathway as well as the lectin pathway. C3a is an anaphylotoxin and the precursor of some cytokines such as ASP, and C3b serves as an opsonizing agent. Factor I can cleave C3b into C3c and C3d, the latter of which plays a role in enhancing B cell responses. In the alternative complement pathway, C3 is cleaved by C3bBb, another form of C3-convertase composed of activated forms of C3 (C3b) and factor B (Bb). Once C3 is activated to C3b, it exposes a reactive thioester that allows the peptide to covalently attach to any surface that can provide a nucleophile such as a primary amine or a hydroxyl group. Activated C3 can then interact with factor B. Factor B is then activated by factor D, to form Bb. The resultant complex, C3bBb, is called the alternative pathway (AP) C3 convertase.C3bBb is deactivated in steps. First, the proteolytic component of the convertase, Bb, is removed by complement regulatory proteins having decay-accelerating factor (DAF) activity. Next, C3b is broken down progressively to first iC3b, then C3c + C3dg, and then finally C3d. Factor I is the protease that performs these cuts with CR1 as cofactor. Clone 1H8 recognize separate, non-overlapping epitopes on C3 fragments. Levels of C3 in the blood may be measured to support or refute a particular medical diagnosis. For example, low C3 levels are associated with some types of kidney disease such as post-infectious glomerulonephritis and shunt nephritis.

Details Cat number & supplier Size Price
MPO, Human, mAb B7 HM2288-100UG · Hycult Biotech
HM2288-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
GILT, Human, mAb MaP.IP30 HM2284-100UG · Hycult Biotech
HM2284-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
NOD1, Human, mAb 2A10 HM2290-100UG · Hycult Biotech
HM2290-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
Galectin-8, Human, mAb 106.1 HM2278-100UG · Hycult Biotech
HM2278-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
NOD2, Human, mAb hNOD2.017 HM2291-100UG · Hycult Biotech
HM2291-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
Complement factor B/Bb, Human, mAb M13/12 HM2256-100UG · Hycult Biotech
HM2256-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
Complement factor B/Ba, Human, mAb M20/6 HM2255-100UG · Hycult Biotech
HM2255-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
B-FABP, Human, mAb 1F5 HM2299-100UG · Hycult Biotech
HM2299-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
Complement factor B/Ba, Human, mAb P21/15 HM2254-100UG · Hycult Biotech
HM2254-100UG
Hycult Biotech
100 µg £410.00
100 µg
view
B-FABP, Human, mAb 2D2 HM2300-100UG · Hycult Biotech
HM2300-100UG
Hycult Biotech
100 µg £410.00
100 µg
view